Showing results (161-170 of 342) with videos related to

Sort By:
Pageof 35
Molecular Genetics and Metabolism|April 9, 2011
A safety trial of high dose glyceryl triacetate for Canavan diseaseReeval Segel, Yair Anikster, Shoshana Zevin, et al.
Systematic Reviews|April 22, 2017
Plasma chitotriosidase activity versus CCL18 level for assessing type I Gaucher disease severity: protocol for a systematic review with meta-analysis of individual participant dataTatiana Raskovalova, Patrick B Deegan, Ruby Yang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 6, 2007
Monitoring of Gaucher patients with a novel chitotriosidase assayAricha Schoonhoven, Bernard Rudensky, Debbie Elstein, et al.
Transplantation|May 3, 2016
Safety of Living Donation of Hematopoietic Stem CellsJeff Szer, Heidi Elmoazzen, Mirjam Fechter, et al.
Molecular Genetics and Metabolism|September 12, 2016
Home infusion of intravenous velaglucerase alfa: Experience from pooled clinical studies in 104 patients with type 1 Gaucher diseaseDeborah Elstein, T Andrew Burrow, Joel Charrow, et al.
British Journal of Haematology|May 29, 2010
Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapyMichael Dickinson, Rosemary Hoyt, Andrew W Roberts, et al.
Blood|March 20, 2010
Phase 1/2 and extension study of velaglucerase alfa replacement therapy in adults with type 1 Gaucher disease: 48-month experienceAri Zimran, Gheona Altarescu, Mici Philips, et al.
International Journal of Molecular Sciences|September 29, 2020
Macular Ganglion Cell Complex and Peripapillary Retinal Nerve Fiber Layer Thinning in Patients with Type-1 Gaucher DiseaseYishay Weill, Ari Zimran, David Zadok, et al.
Journal of Inherited Metabolic Disease|January 6, 2010
Disease severity in sibling pairs with type 1 Gaucher diseaseDeborah Elstein, Ayelet Gellman, Gheona Altarescu, et al.
Plos One|March 12, 2009
A plant-derived recombinant human glucocerebrosidase enzyme--a preclinical and phase I investigationDavid Aviezer, Einat Brill-Almon, Yoseph Shaaltiel, et al.
Pageof 35